Figure 2.
Outcome based on PB blast percentage, as well as cytogenetic markers. OS probability from onset of HMA treatment according to PB blast percentage (>5% vs ≤5%) (A) and cytogenetic risk (intermediate/normal vs poor) (B).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.